Medeon Biodesign, Inc. (TPEX:6499)
81.80
-0.20 (-0.24%)
Apr 29, 2026, 1:30 PM CST
Medeon Biodesign Revenue
In the year 2025, Medeon Biodesign had annual revenue of 419.43M TWD with 43.24% growth. Medeon Biodesign had revenue of 114.87M in the quarter ending December 31, 2025, with 48.51% growth.
Revenue
419.43M
Revenue Growth
+43.24%
P/S Ratio
18.95
Revenue / Employee
10.75M
Employees
39
Market Cap
7.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 419.43M | 126.62M | 43.24% |
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioteque | 2.14B |
| Formosa Optical Technology | 4.13B |
| Vizionfocus | 3.49B |
| Pacific Hospital Supply | 2.41B |
| St.Shine Optical | 4.12B |
| SciVision Biotech | 886.62M |
| Visco Vision | 4.22B |
| Bionime | 1.84B |